trimethoprim has been researched along with miltefosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bekhit, AA; Belal, ASF; El-Din A Bekhit, A; Elzahhar, PA; Labib, HF; Temraz, MG | 1 |
| Abdel-Aziz, HA; Al-Warhi, T; Almahli, H; Bekhit, AA; Boeckler, FM; Eldehna, WM; Fares, M; Ibrahim, TM | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
4 other study(ies) available for trimethoprim and miltefosine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Anti-leishmanial click modifiable thiosemicarbazones: Design, synthesis, biological evaluation and in silico studies.
Topics: Animals; Chlorocebus aethiops; Click Chemistry; Drug Design; Humans; Leishmania major; Leishmaniasis, Cutaneous; Molecular Docking Simulation; Oxidoreductases; Thiosemicarbazones; Trypanocidal Agents; Vero Cells | 2018 |
Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Leishmania major; Models, Molecular; Molecular Structure; Nicotinic Acids; Parasitic Sensitivity Tests; Semicarbazides; Structure-Activity Relationship; Vero Cells | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |